Non-alcoholic fatty liver disease (NAFLD) is common, affecting approximately 25% of the
general population. The evidence base for the investigation and management of NAFLD is …

Polypharmacy describes the concomitant use of multiple medicines and represents a
growing global challenge attributable to aging populations with an increasing prevalence of …

Background & Aims Individuals with cirrhosis discharged from hospital following acute
decompensation are at high risk of new complications. This study aimed to assess the …

Patients with chronic liver disease (CLD) are becoming increasingly complex due to the
rising prevalence of multimorbidity and polypharmacy. Medications are often essential to …

Conclusions RHOF helps tumor cells resist metabolic stress through modulating the
Warburg effect and plays a critical role in promoting HCC cell migration, invasion, and EMT …

Cirrhosis is a morbid condition associated with frequent hospitalizations and high mortality.
Management of cirrhosis requires complex medication regimens to treat underlying liver …

Purpose This review aimed to determine the prevalence, causes and risk factors of medicine-
related problems (MRPs) in patients with liver cirrhosis. Methods Eight online databases …

AIM To investigate the impact of medication beliefs, illness perceptions and quality of life on
medication adherence in people with decompensated cirrhosis. METHODS One hundred …

Cirrhosis is associated with substantial morbidity and mortality. Development of
complications of cirrhosis, including hepatic encephalopathy (HE), portends poorer …

People with chronic disease often have poor comprehension of their disease and
medications, which can negatively affect health outcomes. In a randomised‐controlled trial …